Metavention, Inc. Company Profile

21:06 EDT 26th April 2018 | BioPortfolio

News Articles [3 Associated News Articles listed on BioPortfolio]

Metavention obtains $65M in funding round, names new CEO

A round of Series C financing brought in $65 million for Eden Prairie, Minn.-based Metavention, which intends to use the mone -More- 

Series C lands $65mm for Metavention

Metavention Inc. (diabetes device maker) raised $65mm in its Series C financing led by New Enterprise Associates, which was joined by first-time backers Sanderling Ventures, RK Mellon and Horowitz Gro...

Metavention, Inc., Closes $65 Million in Series C Funding, Appoints New Chief Executive Officer

Capital to enable Phase 2 trials for Metabolic Neuromodulation Therapy, an important new treatment for Type 2 diabetes. Metavention, Inc., today announced the completion of $6...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "Metavention, Inc." on BioPortfolio

We have published hundreds of Metavention, Inc. news stories on BioPortfolio along with dozens of Metavention, Inc. Clinical Trials and PubMed Articles about Metavention, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Metavention, Inc. Companies in our database. You can also find out about relevant Metavention, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record